| LA | |
|---|---|
| Post | - |
| Pre | - |
| M1 | M2 | M3 | M4 | M5 | M6 | M7 | M8 | M9 | M10 | Total | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 0 | - | - | - | - | - | 296.0 | 198.3 | 4.3 | - | - | 498.7 |
| 1 | - | - | - | - | - | 29.0 | 401.7 | 7.7 | - | - | 438.3 |
| LO1 | LO2 | LO3 | LO4 | LO5a | LO5b | LO6 | Total | |
|---|---|---|---|---|---|---|---|---|
| Post | - | - | - | - | - | - | - | - |
| Pre | - | - | - | - | - | - | - | - |
| AME | |
|---|---|
| 0 | 5.7 |
| 1 | 3.3 |
| LOP1 | LOP2 | LOP3 | LOP4 | Total | |
|---|---|---|---|---|---|
| Post | - | - | - | - | - |
| Pre | - | - | - | - | - |
| central brain | |
|---|---|
| 0 | - |
| 1 | - |
| Number of post synapses: | 1496 |
| Number of pre synapses: | 1315 |
| Number of output connections: | 3929 |
| Coverage factor: | 1.3 |
| Columnar completeness: | 0.43 |
| Area completeness: | 0.92 |
| Cell size (columns): | 93 |
| Number of post synapses: | 0 |
| Number of pre synapses: | 0 |
| Number of output connections: | 0 |
| Coverage factor: | 0 |
| Columnar completeness: | 0 |
| Area completeness: | 0 |
| Cell size (columns): | 0 |
| Number of post synapses: | 0 |
| Number of pre synapses: | 0 |
| Number of output connections: | 0 |
| Coverage factor: | 0 |
| Columnar completeness: | 0 |
| Area completeness: | 0 |
| Cell size (columns): | 0 |
| instance | NT | total connections | connections /#Cm25 (R) | % | % cumu. | |
|---|---|---|---|---|---|---|
| 0 | Dm2 (R) | ACh | 344 | 114.7 | 22.9% | 22.9% |
| 1 | MeVPMe5 (L) | Glu | 193 | 64.3 | 12.9% | 35.8% |
| 2 | MeTu1 (R) | ACh | 182 | 60.7 | 12.1% | 47.9% |
| 3 | MeVC8 (L) | ACh | 75 | 25.0 | 5.0% | 52.9% |
| 4 | MeVC5 (L) | ACh | 69 | 23.0 | 4.6% | 57.5% |
| 5 | Cm25 (R) | Glu | 47 | 15.7 | 3.1% | 60.6% |
| 6 | MeVPMe9 (L) | Glu | 35 | 11.7 | 2.3% | 63.0% |
| 7 | MeVC9 (L) | ACh | 34 | 11.3 | 2.3% | 65.2% |
| 8 | Cm3 (R) | GABA | 27 | 9.0 | 1.8% | 67.0% |
| 9 | MeTu3b (R) | ACh | 27 | 9.0 | 1.8% | 68.8% |
| 10 | Cm5 (R) | GABA | 26 | 8.7 | 1.7% | 70.6% |
| 11 | MeLo6 (R) | ACh | 22 | 7.3 | 1.5% | 72.0% |
| 12 | MeVC2 (L) | ACh | 20 | 6.7 | 1.3% | 73.4% |
| 13 | MeVP6 (R) | Glu | 20 | 6.7 | 1.3% | 74.7% |
| 14 | Cm4 (R) | Glu | 19 | 6.3 | 1.3% | 75.9% |
| 15 | Cm34 (R) | Glu | 18 | 6.0 | 1.2% | 77.1% |
| 16 | MeVPMe10 (L) | Glu | 18 | 6.0 | 1.2% | 78.3% |
| 17 | OA-AL2i4 (R) | OA | 17 | 5.7 | 1.1% | 79.5% |
| 18 | MeVC27 (L) | unclear | 15 | 5.0 | 1.0% | 80.5% |
| 19 | aMe10 (R) | ACh | 14 | 4.7 | 0.9% | 81.4% |
| 20 | MeVC7a (L) | ACh | 14 | 4.7 | 0.9% | 82.3% |
| 21 | aMe4 (R) | ACh | 13 | 4.3 | 0.9% | 83.2% |
| 22 | aMe5 (R) | ACh | 13 | 4.3 | 0.9% | 84.1% |
| 23 | Mi15 (R) | ACh | 13 | 4.3 | 0.9% | 84.9% |
| 24 | Cm9 (R) | Glu | 12 | 4.0 | 0.8% | 85.7% |
| 25 | Tm38 (R) | ACh | 12 | 4.0 | 0.8% | 86.5% |
| 26 | Cm12 (R) | GABA | 11 | 3.7 | 0.7% | 87.3% |
| 27 | Cm16 (R) | Glu | 10 | 3.3 | 0.7% | 87.9% |
| 28 | Cm6 (R) | GABA | 9 | 3.0 | 0.6% | 88.5% |
| 29 | MeVP7 (R) | ACh | 9 | 3.0 | 0.6% | 89.1% |
| 30 | MeVPMe8 (R) | Glu | 8 | 2.7 | 0.5% | 89.7% |
| 31 | Cm23 (R) | Glu | 6 | 2.0 | 0.4% | 90.1% |
| 32 | Cm8 (R) | GABA | 6 | 2.0 | 0.4% | 90.5% |
| 33 | MeVP11 (R) | ACh | 6 | 2.0 | 0.4% | 90.9% |
| 34 | TmY17 (R) | ACh | 6 | 2.0 | 0.4% | 91.3% |
| 35 | MeTu3c (R) | ACh | 5 | 1.7 | 0.3% | 91.6% |
| 36 | MeVPMe2 (R) | Glu | 5 | 1.7 | 0.3% | 91.9% |
| 37 | aMe17a (R) | Glu | 4 | 1.3 | 0.3% | 92.2% |
| 38 | Cm14 (R) | GABA | 4 | 1.3 | 0.3% | 92.5% |
| 39 | Cm20 (R) | GABA | 4 | 1.3 | 0.3% | 92.7% |
| 40 | Cm21 (R) | GABA | 4 | 1.3 | 0.3% | 93.0% |
| 41 | MeVP1 (R) | ACh | 4 | 1.3 | 0.3% | 93.3% |
| 42 | MeVP12 (R) | ACh | 4 | 1.3 | 0.3% | 93.5% |
| 43 | MeVPMe3 (L) | Glu | 4 | 1.3 | 0.3% | 93.8% |
| 44 | MeVPMe6 (L) | Glu | 4 | 1.3 | 0.3% | 94.1% |
| 45 | Cm30 (R) | GABA | 3 | 1.0 | 0.2% | 94.3% |
| 46 | Cm31b (R) | GABA | 3 | 1.0 | 0.2% | 94.5% |
| 47 | Cm_unclear (R) | ACh | 3 | 1.0 | 0.2% | 94.7% |
| 48 | Lat3 (R) | unclear | 3 | 1.0 | 0.2% | 94.9% |
| 49 | MeTu4c (R) | ACh | 3 | 1.0 | 0.2% | 95.1% |
| 50 | MeVP14 (R) | ACh | 3 | 1.0 | 0.2% | 95.3% |
| 51 | MeVP32 (R) | ACh | 3 | 1.0 | 0.2% | 95.5% |
| 52 | MeVP9 (R) | ACh | 3 | 1.0 | 0.2% | 95.7% |
| 53 | TmY18 (R) | ACh | 3 | 1.0 | 0.2% | 95.9% |
| instance | NT | total connections | connections /#Cm25 (R) | % | % cumu. | |
|---|---|---|---|---|---|---|
| 0 | Cm12 (R) | GABA | 585 | 195.0 | 14.7% | 14.7% |
| 1 | Cm8 (R) | GABA | 571 | 190.3 | 14.4% | 29.1% |
| 2 | Cm3 (R) | GABA | 430 | 143.3 | 10.8% | 39.9% |
| 3 | Cm5 (R) | GABA | 270 | 90.0 | 6.8% | 46.7% |
| 4 | Cm14 (R) | GABA | 153 | 51.0 | 3.9% | 50.6% |
| 5 | MeLo6 (R) | ACh | 121 | 40.3 | 3.0% | 53.6% |
| 6 | Tm16 (R) | ACh | 106 | 35.3 | 2.7% | 56.3% |
| 7 | MeTu4f (R) | ACh | 95 | 31.7 | 2.4% | 58.7% |
| 8 | Cm10 (R) | GABA | 91 | 30.3 | 2.3% | 60.9% |
| 9 | Cm16 (R) | Glu | 84 | 28.0 | 2.1% | 63.1% |
| 10 | MeTu4a (R) | ACh | 82 | 27.3 | 2.1% | 65.1% |
| 11 | MeTu3b (R) | ACh | 81 | 27.0 | 2.0% | 67.2% |
| 12 | Tm26 (R) | ACh | 74 | 24.7 | 1.9% | 69.0% |
| 13 | MeTu4c (R) | ACh | 73 | 24.3 | 1.8% | 70.9% |
| 14 | MeTu1 (R) | ACh | 70 | 23.3 | 1.8% | 72.6% |
| 15 | MeVP8 (R) | ACh | 53 | 17.7 | 1.3% | 74.0% |
| 16 | MeLo5 (R) | ACh | 50 | 16.7 | 1.3% | 75.2% |
| 17 | Cm20 (R) | GABA | 49 | 16.3 | 1.2% | 76.4% |
| 18 | Cm34 (R) | Glu | 48 | 16.0 | 1.2% | 77.7% |
| 19 | Cm25 (R) | Glu | 47 | 15.7 | 1.2% | 78.8% |
| 20 | TmY18 (R) | ACh | 40 | 13.3 | 1.0% | 79.8% |
| 21 | MeTu4d (R) | ACh | 37 | 12.3 | 0.9% | 80.8% |
| 22 | Pm12 (R) | Glu | 36 | 12.0 | 0.9% | 81.7% |
| 23 | MeTu3c (R) | ACh | 35 | 11.7 | 0.9% | 82.6% |
| 24 | MeVP7 (R) | ACh | 35 | 11.7 | 0.9% | 83.4% |
| 25 | Tm35 (R) | Glu | 34 | 11.3 | 0.9% | 84.3% |
| 26 | Cm17 (R) | GABA | 30 | 10.0 | 0.8% | 85.1% |
| 27 | TmY21 (R) | ACh | 30 | 10.0 | 0.8% | 85.8% |
| 28 | Dm2 (R) | ACh | 25 | 8.3 | 0.6% | 86.4% |
| 29 | Mi15 (R) | ACh | 23 | 7.7 | 0.6% | 87.0% |
| 30 | Tm34 (R) | Glu | 21 | 7.0 | 0.5% | 87.5% |
| 31 | MeVP14 (R) | ACh | 20 | 6.7 | 0.5% | 88.0% |
| 32 | Tm36 (R) | ACh | 20 | 6.7 | 0.5% | 88.6% |
| 33 | TmY10 (R) | ACh | 17 | 5.7 | 0.4% | 89.0% |
| 34 | Tm37 (R) | Glu | 16 | 5.3 | 0.4% | 89.4% |
| 35 | MeVPMe8 (R) | Glu | 15 | 5.0 | 0.4% | 89.8% |
| 36 | Cm6 (R) | GABA | 14 | 4.7 | 0.4% | 90.1% |
| 37 | Pm13 (R) | Glu | 14 | 4.7 | 0.4% | 90.5% |
| 38 | Mi18 (R) | GABA | 13 | 4.3 | 0.3% | 90.8% |
| 39 | MeTu4e (R) | ACh | 10 | 3.3 | 0.3% | 91.0% |
| 40 | MeVP59 (R) | ACh | 10 | 3.3 | 0.3% | 91.3% |
| 41 | aMe26 (R) | ACh | 9 | 3.0 | 0.2% | 91.5% |
| 42 | MeVPMe5 (R) | Glu | 9 | 3.0 | 0.2% | 91.7% |
| 43 | Mi16 (R) | GABA | 9 | 3.0 | 0.2% | 92.0% |
| 44 | Tm38 (R) | ACh | 9 | 3.0 | 0.2% | 92.2% |
| 45 | aMe4 (R) | ACh | 8 | 2.7 | 0.2% | 92.4% |
| 46 | MeLo7 (R) | ACh | 8 | 2.7 | 0.2% | 92.6% |
| 47 | MeVC22 (R) | Glu | 8 | 2.7 | 0.2% | 92.8% |
| 48 | TmY4 (R) | ACh | 8 | 2.7 | 0.2% | 93.0% |
| 49 | Mi17 (R) | GABA | 7 | 2.3 | 0.2% | 93.2% |
| 50 | Tm33 (R) | ACh | 7 | 2.3 | 0.2% | 93.4% |
| 51 | aMe9 (R) | ACh | 6 | 2.0 | 0.2% | 93.5% |
| 52 | MeVP33 (R) | ACh | 6 | 2.0 | 0.2% | 93.7% |
| 53 | T2 (R) | ACh | 6 | 2.0 | 0.2% | 93.8% |
| 54 | aMe5 (R) | ACh | 5 | 1.7 | 0.1% | 93.9% |
| 55 | Cm22 (R) | GABA | 5 | 1.7 | 0.1% | 94.1% |
| 56 | Cm30 (R) | GABA | 5 | 1.7 | 0.1% | 94.2% |
| 57 | Cm35 (R) | GABA | 5 | 1.7 | 0.1% | 94.3% |
| 58 | Cm7 (R) | Glu | 5 | 1.7 | 0.1% | 94.4% |
| 59 | MeLo1 (R) | ACh | 5 | 1.7 | 0.1% | 94.6% |
| 60 | MeVPMe13 (R) | ACh | 5 | 1.7 | 0.1% | 94.7% |
| 61 | Tm5c (R) | Glu | 5 | 1.7 | 0.1% | 94.8% |
| 62 | Y14 (R) | Glu | 5 | 1.7 | 0.1% | 94.9% |
| 63 | Cm31b (R) | GABA | 4 | 1.3 | 0.1% | 95.0% |
| 64 | Cm9 (R) | Glu | 4 | 1.3 | 0.1% | 95.1% |
| 65 | Lawf1 (R) | ACh | 4 | 1.3 | 0.1% | 95.2% |
| 66 | MeLo3b (R) | ACh | 4 | 1.3 | 0.1% | 95.3% |
| 67 | MeVC27 (L) | unclear | 4 | 1.3 | 0.1% | 95.4% |
| 68 | MeVP21 (R) | ACh | 4 | 1.3 | 0.1% | 95.5% |
| 69 | MeVP55 (R) | unclear | 4 | 1.3 | 0.1% | 95.6% |
| 70 | MeVP9 (R) | ACh | 4 | 1.3 | 0.1% | 95.7% |
| 71 | MeVPMe6 (R) | Glu | 4 | 1.3 | 0.1% | 95.8% |
| 72 | Mi19 (R) | 5HT | 4 | 1.3 | 0.1% | 95.9% |
| 73 | Tm5a (R) | ACh | 4 | 1.3 | 0.1% | 96.0% |
| 74 | Tm5b (R) | ACh | 4 | 1.3 | 0.1% | 96.1% |
| 75 | aMe17a (R) | Glu | 3 | 1.0 | 0.1% | 96.2% |
| 76 | C3 (R) | GABA | 3 | 1.0 | 0.1% | 96.3% |
| 77 | Cm21 (R) | GABA | 3 | 1.0 | 0.1% | 96.4% |
| 78 | Cm24 (R) | Glu | 3 | 1.0 | 0.1% | 96.5% |
| 79 | Cm33 (R) | GABA | 3 | 1.0 | 0.1% | 96.5% |
| 80 | Cm4 (R) | Glu | 3 | 1.0 | 0.1% | 96.6% |
| 81 | l-LNv (R) | unclear | 3 | 1.0 | 0.1% | 96.7% |
| 82 | MeVP15 (R) | ACh | 3 | 1.0 | 0.1% | 96.8% |
| 83 | MeVP6 (R) | Glu | 3 | 1.0 | 0.1% | 96.8% |
| 84 | MeVPLo1 (R) | Glu | 3 | 1.0 | 0.1% | 96.9% |
| 85 | T2a (R) | ACh | 3 | 1.0 | 0.1% | 97.0% |
| 86 | Tm2 (R) | ACh | 3 | 1.0 | 0.1% | 97.1% |
| 87 | Tm5Y (R) | ACh | 3 | 1.0 | 0.1% | 97.1% |
| 88 | Tm6 (R) | ACh | 3 | 1.0 | 0.1% | 97.2% |
| 89 | Tm9 (R) | ACh | 3 | 1.0 | 0.1% | 97.3% |
| 90 | TmY17 (R) | ACh | 3 | 1.0 | 0.1% | 97.4% |
| 91 | TmY5a (R) | Glu | 3 | 1.0 | 0.1% | 97.4% |
| 92 | TmY9a (R) | ACh | 3 | 1.0 | 0.1% | 97.5% |
| 93 | TmY9b (R) | ACh | 3 | 1.0 | 0.1% | 97.6% |